Company Filing History:
Years Active: 2013
Title: Martin Tolstrup: Innovator in Chimeric Viral Envelopes
Introduction
Martin Tolstrup is a notable inventor based in Aarhus N, Denmark. He has made significant contributions to the field of virology through his innovative work on chimeric viral envelopes. His research focuses on the development of polytropic viral envelope polypeptides and their applications in targeted therapies.
Latest Patents
Tolstrup holds a patent for his invention titled "Chimeric Viral Envelopes." This invention relates to chimeric polytropic viral envelope polypeptides and their uses, as well as polynucleotides encoding these chimeric polypeptides. The invention also encompasses chimeric retroviral envelope polypeptides, polynucleotides, and vectors that encode these polypeptides. The chimeric polypeptides consist of an envelope polypeptide or a fragment thereof, along with a polypeptide sequence of a receptor binding region or ligand. Additionally, the invention includes methods for targeting receptors, treatment methods, and delivery methods using these chimeric retroviral envelope polypeptides. This innovation is particularly applicable for directed targeting and controlled fusion of virus particles with cellular membranes. Tolstrup has 1 patent to his name.
Career Highlights
Martin Tolstrup is affiliated with Aarhus Universitet, where he conducts his research and development work. His contributions to the field of virology have positioned him as a key figure in the study of viral envelope technologies.
Collaborations
Tolstrup has collaborated with notable colleagues, including Finn Skou Pedersen and Shervin Bahrami. Their combined expertise has further advanced the research in chimeric viral envelopes.
Conclusion
Martin Tolstrup's innovative work in the field of chimeric viral envelopes showcases his dedication to advancing virology. His patent and research contributions are paving the way for new therapeutic approaches in targeted viral treatments.